{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:07:04Z","timestamp":1787929624287,"version":"build-2784847793"},"reference-count":71,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008879","name":"Japanese Foundation for Prostate Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.prnil.2022.03.004","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:05:44Z","timestamp":1648559144000},"page":"96-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Prostate diseases and microbiome in the prostate, gut, and urine"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9503-7356","authenticated-orcid":false,"given":"Makito","family":"Miyake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-6889","authenticated-orcid":false,"given":"Yoshihiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7207-4127","authenticated-orcid":false,"given":"Tomomi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobumichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.prnil.2022.03.004_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002533","article-title":"Revised Estimates for the Number of Human and Bacteria Cells in the Body","volume":"14","author":"Sender","year":"2016","journal-title":"PLoS Biol"},{"issue":"9","key":"10.1016\/j.prnil.2022.03.004_bib2","first-page":"560","article-title":"Gut bacteria in health and disease","volume":"9","author":"Quigley","year":"2013","journal-title":"Gastroenterol Hepatol"},{"issue":"19","key":"10.1016\/j.prnil.2022.03.004_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.21037\/atm-20-2976","article-title":"The human microbiome and genitourinary malignancies","volume":"8","author":"Nicolaro","year":"2020","journal-title":"Ann Transl Med"},{"issue":"7164","key":"10.1016\/j.prnil.2022.03.004_bib4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prnil.2022.03.004_bib5","first-page":"3039","article-title":"The Urethral Microbiota - A Missing Link in the Female Urinary Microbiota","volume":"204","author":"Chen","year":"2020","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1373\/clinchem.2012.187617","article-title":"The human gut microbiome and body metabolism: implications for obesity and diabetes","volume":"59","author":"Devaraj","year":"2013","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.prnil.2022.03.004_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib8","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1038\/s41598-017-11237-6","article-title":"Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer","volume":"7","author":"Purcell","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/cells8030212","article-title":"Mycoplasma genitalium Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy Specimens","volume":"8","author":"Miyake","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib10","first-page":"1224","article-title":"How common is prostatitis? A national survey of physician visits","volume":"159","author":"Collins","year":"1998","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0090-4295(98)00034-X","article-title":"Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men","volume":"51","author":"Roberts","year":"1998","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.prnil.2022.03.004_bib12","first-page":"30","article-title":"UTId chronic prostatitis\/chronic pelvic pain syndrome","volume":"5","year":"2017","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/andr.12647","article-title":"Dramatically deteriorated quality of life in men with prostatitis-like symptoms","volume":"8","author":"M\u00e4ndar","year":"2020","journal-title":"Andrology"},{"issue":"5","key":"10.1016\/j.prnil.2022.03.004_bib14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2605.2008.00878.x","article-title":"Microflora of the seminal fluid of healthy men and men suffering from chronic prostatitis syndrome","volume":"32","author":"Ivanov","year":"2009","journal-title":"Int J Androl"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2605.2009.00969.x","article-title":"Phenotypic differences between coagulase-negative staphylococci isolated from seminal fluid of healthy men and men suffering from chronic prostatitis syndrome","volume":"33","author":"Ivanov IB","year":"2010","journal-title":"Int J Androl"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.12954\/PI.13023","article-title":"Microbiological etiology of bacterial prostatitis in general hospital and primary care clinic in Korea","volume":"1","author":"Choi","year":"2013","journal-title":"Prostate Int"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib17","first-page":"127","article-title":"Search for Microorganisms in Men with Urologic Chronic Pelvic Pain Syndrome: A Culture-Independent Analysis in the MAPP Research Network","volume":"194","author":"Nickel","year":"2015","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.prnil.2022.03.004_bib18","first-page":"435","article-title":"Analysis of Gut Microbiome Reveals Significant Differences between Men with Chronic Prostatitis\/Chronic Pelvic Pain Syndrome and Controls","volume":"196","author":"Shoskes","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.prnil.2022.03.004_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.urology.2016.02.043","article-title":"The Urinary Microbiome Differs Significantly Between Patients With Chronic Prostatitis\/Chronic Pelvic Pain Syndrome and Controls as Well as Between Patients With Different Clinical Phenotypes","volume":"92","author":"Shoskes","year":"2016","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/iju.13286","article-title":"Seminal microbiome in men with and without prostatitis","volume":"24","author":"M\u00e4ndar","year":"2017","journal-title":"Int J Urol"},{"issue":"2","key":"10.1016\/j.prnil.2022.03.004_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.21037\/tau.2020.02.05","article-title":"Analysis of bacterial community using pyrosequencing in semen from patients with chronic pelvic pain syndrome: a pilot study","volume":"9","author":"Choi","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"7","key":"10.1016\/j.prnil.2022.03.004_bib22","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/pros.23971","article-title":"Screening for chronic prostatitis pathogens using high-throughput next-generation sequencing","volume":"80","author":"Wu","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.prnil.2022.03.004_bib23","first-page":"1007366","article-title":"Microbiota, Prostatitis, and Fertility: Bacterial Diversity as a Possible Health Ally","volume":"28","author":"Su\u00e1rez","year":"2021","journal-title":"Adv Urol"},{"issue":"12","key":"10.1016\/j.prnil.2022.03.004_bib24","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/iju.14685","article-title":"Does the microbiota spectrum of prostate secretion affect the clinical status of patients with chronic bacterial prostatitis?","volume":"28","author":"Kogan","year":"2021","journal-title":"Int J Urol"},{"key":"10.1016\/j.prnil.2022.03.004_bib25","first-page":"75","article-title":"Inflammatory mechanisms and oxidative stress in prostatitis: the possible role of antioxidant therapy","volume":"10","author":"Paulis","year":"2018","journal-title":"Res Rep Urol"},{"issue":"6","key":"10.1016\/j.prnil.2022.03.004_bib26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4111\/icu.2017.58.6.460","article-title":"Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study","volume":"58","author":"Cai","year":"2017","journal-title":"Investig Clin Urol"},{"issue":"10","key":"10.1016\/j.prnil.2022.03.004_bib27","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/cid\/cir183","article-title":"Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection","volume":"52","author":"Stapleton","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.prnil.2020.04.002","article-title":"Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia-related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity","volume":"8","author":"Gul","year":"2020","journal-title":"Prostate Int"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"Roehrborn","year":"2010","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.prnil.2022.03.004_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00192-015-2847-x","article-title":"Incontinence medication response relates to the female urinary microbiota","volume":"27","author":"Thomas-White","year":"2016","journal-title":"Int Urogynecol J"},{"issue":"12","key":"10.1016\/j.prnil.2022.03.004_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11934-014-0463-9","article-title":"The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy","volume":"15","author":"Ficarra","year":"2014","journal-title":"Curr Urol Rep"},{"issue":"2","key":"10.1016\/j.prnil.2022.03.004_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/MOU.0000000000000369","article-title":"The role of prostatic inflammation in the development and progression of benign and malignant diseases","volume":"27","author":"Gandaglia","year":"2017","journal-title":"Curr Opin Urol"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib33","first-page":"161","article-title":"Profiling the urinary microbiome in men with positive versus negative biopsies for prostate cancer","volume":"199","author":"Shrestha","year":"2018","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.prnil.2022.03.004_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5114\/aoms.2015.50970","article-title":"Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia","volume":"11","author":"Yu","year":"2015","journal-title":"Arch Med Sci"},{"issue":"2","key":"10.1016\/j.prnil.2022.03.004_bib35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.euf.2018.08.001","article-title":"Male bladder microbiome relates to lower urinary tract symptoms","volume":"6","author":"Bajic","year":"2020","journal-title":"Eur Urol Focus"},{"issue":"6","key":"10.1016\/j.prnil.2022.03.004_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/bju.14972","article-title":"The effect of the urinary and faecal microbiota on lower urinary tract symptoms measured by the International Prostate Symptom Score: analysis utilising next-generation sequencing","volume":"125","author":"Holland","year":"2020","journal-title":"BJU Int"},{"issue":"15","key":"10.1016\/j.prnil.2022.03.004_bib37","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/pros.24063","article-title":"Escherichia coli, a common constituent of benign prostate hyperplasia-associated microbiota induces inflammation and DNA damage in prostate epithelial cells","volume":"80","author":"Jain","year":"2020","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12941-021-00428-9","article-title":"The impact of urine microbiota in patients with lower urinary tract symptoms","volume":"20","author":"Lee","year":"2021","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.prnil.2022.03.004_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fcimb.2013.00041","article-title":"The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults","volume":"3","author":"Lewis","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.critrevonc.2008.07.021","article-title":"Infections and cancer: established associations and new hypotheses","volume":"70","author":"de Martel","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"10.1016\/j.prnil.2022.03.004_bib41","first-page":"1519","article-title":"Prophylaxis of cancer of the prostate, penis, and cervix by circumcision","volume":"51","author":"Ravich","year":"1951","journal-title":"N\u00a0Y State J Med"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrurol.2017.167","article-title":"The inflammatory microenvironment and microbiome in prostate cancer development","volume":"15","author":"Sfanos","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.eururo.2017.03.029","article-title":"The Microbiome of the Prostate Tumor Microenvironment","volume":"72","author":"Cavarretta","year":"2017","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.prnil.2022.03.004_bib44","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.7314\/APJCP.2013.14.6.3425","article-title":"Mycoplasma genitalium and cancer: A brief review","volume":"14","author":"Zarei","year":"2013","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41391-018-0041-1","article-title":"The Microbiome in Prostate Inflammation and Prostate Cancer","volume":"21","author":"Porter","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.prnil.2022.03.004_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.eururo.2018.06.033","article-title":"Metabolic Biosynthesis Pathways Identified from Fecal Microbiome Associated with Prostate Cancer","volume":"74","author":"Liss","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2022.03.004_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2017.08.039","article-title":"The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study","volume":"111","author":"Golombos","year":"2018","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41391-018-0061-x","article-title":"Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies","volume":"21","author":"Sfanos","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pros.23713","article-title":"A\u00a0prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysis","volume":"79","author":"Alanee","year":"2019","journal-title":"Prostate"},{"issue":"8","key":"10.1016\/j.prnil.2022.03.004_bib50","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1111\/cas.14998","article-title":"The gut microbiota associated with high-Gleason prostate cancer","volume":"112","author":"Matsushita","year":"2021","journal-title":"Cancer Sci"},{"issue":"5","key":"10.1016\/j.prnil.2022.03.004_bib51","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.21037\/tau-20-566","article-title":"Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer","volume":"9","author":"Liu","year":"2020","journal-title":"Transl Androl Urol"},{"issue":"15","key":"10.1016\/j.prnil.2022.03.004_bib52","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/0008-5472.CAN-20-4090","article-title":"Gut Microbiota-Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling","volume":"81","author":"Matsushita","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.prnil.2022.03.004_bib53","doi-asserted-by":"crossref","first-page":"100593","DOI":"10.1016\/j.conctc.2020.100593","article-title":"A\u00a0prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study","volume":"19","author":"Miyake","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib54","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/pros.23740","article-title":"Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model","volume":"79","author":"Miyake","year":"2019","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12894-017-0251-1","article-title":"Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute","volume":"17","author":"Miyake","year":"2017","journal-title":"BMC Urol"},{"issue":"21","key":"10.1016\/j.prnil.2022.03.004_bib56","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1158\/1078-0432.CCR-19-0960","article-title":"Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy","volume":"25","author":"Reis Ferreira","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib57","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J Clin"},{"issue":"1","key":"10.1016\/j.prnil.2022.03.004_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7314\/APJCP.2013.14.1.1","article-title":"Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk","volume":"14","author":"Sugiyama","year":"2013","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib59","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.23594","article-title":"Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study","volume":"123","author":"Park","year":"2008","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.prnil.2022.03.004_bib60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3839\/jabc.2008.040","article-title":"Isoflavone daidzein: chemistry and bacterial metabolism","volume":"51","author":"Kim","year":"2008","journal-title":"J\u00a0Appl Biol Chem"},{"issue":"4","key":"10.1016\/j.prnil.2022.03.004_bib61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00203-010-0546-z","article-title":"Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS","volume":"192","author":"Tsuji","year":"2010","journal-title":"Arch Microbiol"},{"issue":"6","key":"10.1016\/j.prnil.2022.03.004_bib62","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1349-7006.2012.02257.x","article-title":"Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the \"second human genome\"","volume":"103","author":"Akaza","year":"2012","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.pcan.4501030","article-title":"Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men","volume":"11","author":"Fujimoto","year":"2008","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"10.1016\/j.prnil.2022.03.004_bib64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/pcan.2009.10","article-title":"Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers","volume":"12","author":"Tanaka","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"9","key":"10.1016\/j.prnil.2022.03.004_bib65","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s11255-016-1335-7","article-title":"Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men","volume":"48","author":"Nagata","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"10.1016\/j.prnil.2022.03.004_bib66","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.31640","article-title":"Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls","volume":"143","author":"Perez-Cornago","year":"2018","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.prnil.2022.03.004_bib67","first-page":"1857","article-title":"A\u00a0prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii","volume":"49","author":"Severson","year":"1989","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.prnil.2022.03.004_bib68","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/pros.22712","article-title":"Genistein versus ICI 182, 780: an ally or enemy in metastatic progression of prostate cancer","volume":"73","author":"Nakamura","year":"2013","journal-title":"Prostate"},{"issue":"19","key":"10.1016\/j.prnil.2022.03.004_bib69","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-10-1208","article-title":"AACR special conference on epithelial\u2013mesenchymal transition and cancer progression and treatment","volume":"70","author":"Roussos","year":"2010","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.prnil.2022.03.004_bib70","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/pros.20488","article-title":"Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis","volume":"66","author":"Xu","year":"2006","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.prnil.2022.03.004_bib71","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.31557\/APJCP.2020.21.12.3743","article-title":"Inhibitory Effect of Orally Administered 5-Aminolevulinic Acid on Prostate Carcinogenesis in the FVB-Transgenic Adenocarcinoma of a Mouse Prostate (FVB-TRAMP) Model","volume":"21","author":"Onishi","year":"2020","journal-title":"Asian Pac J Cancer Prev APJCP"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888222000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888222000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:01:02Z","timestamp":1762419662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888222000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2287888222000174"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2022.03.004","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate diseases and microbiome in the prostate, gut, and urine","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2022.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Asian Pacific Prostate Society. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}